Bionano Genomics
BNGO
110 hedge funds and large institutions have $349M invested in Bionano Genomics in 2021 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 13 closing their positions.
802% more capital invested
Capital invested by funds: $38.7M → $349M (+$310M)
477% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 13
333% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 6
129% more funds holding
Funds holding: 48 → 110 (+62)
22% more call options, than puts
Call options by funds: $47.3M | Put options by funds: $38.8M
7.34% more ownership
Funds ownership: 8.17% → 15.51% (+7.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$89.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$39.4M |
| 3 |
BlackRock
New York
|
+$31.9M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$23.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$10.3M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$496K |
| 3 |
Squarepoint
New York
|
-$167K |
| 4 |
CAM
Carret Asset Management
New York
|
-$95.8K |
| 5 |
TWM
Triton Wealth Management
Sun City,
Arizona
|
-$93K |
BNGO Hedge Fund Activity: Q1 2021 in Review
110 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q1 2021, worth a combined $349M — up 802% from $38.7M a quarter earlier.
Buyers outnumbered sellers: 75 funds opened new BNGO positions and 13 closed out — a net gain of 62 holders — while 26 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $89.1M. The largest seller was Pura Vida Investments, cutting an estimated $10.3M.
- 110 institutional investors held Bionano Genomics (BNGO) as of Q1 2021, up from 48 in Q4 2020.
- Funds reported $349M of Bionano Genomics stock for Q1 2021, up 802% quarter-over-quarter.
- 75 funds opened new Bionano Genomics positions in Q1 2021 and 13 closed out, a net change of +62 holders.
- The largest Bionano Genomics buyer in Q1 2021 was Renaissance Technologies, an estimated $89.1M added.
- The largest Bionano Genomics seller in Q1 2021 was Pura Vida Investments, an estimated $10.3M sold.
Based on aggregated 13F filings for Q1 2021.